{"id":764,"date":"2017-02-14T08:53:10","date_gmt":"2017-02-14T07:53:10","guid":{"rendered":"http:\/\/intervacc.se\/en\/?page_id=764"},"modified":"2025-02-12T17:59:06","modified_gmt":"2025-02-12T16:59:06","slug":"patents","status":"publish","type":"page","link":"https:\/\/intervacc.se\/en\/research\/patents\/","title":{"rendered":"Patents"},"content":{"rendered":"<div class=\"preamble\">\n<p>Intervacc work with an active patent strategy, which implies that applications for patents and trademark protection are submitted in the countries that are considered to have great market potential or are considered to be key markets for the product in question.<\/p>\n<\/div>\n<p>The company own five published patent families. The published patent families include a total of about 20 issued patents in various countries and further patents pending.<\/p>\n<p>The five published patent families are:<\/p>\n<ul class=\"list-style\">\n<li>Trivac, WO 2004\/032957 A1, (priority\u00a0year 2002).<br \/>\nPatent granted and in force in USA (until 2028).<\/li>\n<li>Penta\/Septavacc, WO 2009\/075646 A1, (priority\u00a0year 2007).<br \/>\nPatents granted and in force in Europe and USA.<\/li>\n<li>Strangvac<sup>\u00ae<\/sup> , WO 2011\/149419 A1 (priority year 2010)<br \/>\nPatents granted and in force in Europe, USA (US 9,795,664), Hong Kong, China and Australia until 2031 with supplementary protection extended or in progress in Europ\u00e9 until 2036.<\/li>\n<li><em>S.suis<\/em> vaccine, WO 2017\/005913 A1 (priority year 2015)<br \/>\nPatent granted in USA (US 11,155,585) and application in progress in Europe.<\/li>\n<li><em>S. suis<\/em> vaccine, WO 2023\/203238 A1 (priority year 2023). Application in progress in Europe, USA, Canada and China.<\/li>\n<\/ul>\n<p>The primary purpose of the patents is related to protecting the company&#8217;s vaccine product <a href=\"http:\/\/intervacc.se\/en\/research\/pipeline\/strangvac\/\">Strangvac<sup>\u00ae<\/sup><\/a>.<\/p>\n<p>In addition, one patent application describes the possibility of developing vaccine products against diseases caused by <a href=\"http:\/\/intervacc.se\/en\/research\/pipeline\/inv-274\/about-s-suis\/\"><em>Streptococcus zooepidemicus<\/em><\/a>.\u00a0The application describes in detail the various vaccine components, and the development and application method.\u00a0Furthermore, the application also describes different combinations of vaccine formulations tested in animal experiments including mouse and horse.<\/p>\n<p>In addition to patents, the trademark for the vaccine Strangvac<sup>\u00ae<\/sup>\u00a0is registered as an approved drug name.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Intervacc work with an active patent strategy, which implies that applications for patents and trademark protection are submitted in the countries that are considered to have great market potential or are considered to be key markets for the product in question. The company own five published patent families. The published patent families include a total [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":754,"menu_order":3,"comment_status":"closed","ping_status":"closed","template":"","meta":{"inline_featured_image":false},"_links":{"self":[{"href":"https:\/\/intervacc.se\/en\/wp-json\/wp\/v2\/pages\/764"}],"collection":[{"href":"https:\/\/intervacc.se\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/intervacc.se\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/intervacc.se\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/intervacc.se\/en\/wp-json\/wp\/v2\/comments?post=764"}],"version-history":[{"count":20,"href":"https:\/\/intervacc.se\/en\/wp-json\/wp\/v2\/pages\/764\/revisions"}],"predecessor-version":[{"id":732556,"href":"https:\/\/intervacc.se\/en\/wp-json\/wp\/v2\/pages\/764\/revisions\/732556"}],"up":[{"embeddable":true,"href":"https:\/\/intervacc.se\/en\/wp-json\/wp\/v2\/pages\/754"}],"wp:attachment":[{"href":"https:\/\/intervacc.se\/en\/wp-json\/wp\/v2\/media?parent=764"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}